glp-1 obesity drugs pipeline First in class, best in class or a wild card: who will dominate the anti-obesity medication market? Upcoming wave of hormone-based therapies

GLP-1 Receptor Agonists: Mechanism and Benefits GLP-1 receptor agonists are medications that mimic the effects of the natural GLP-1 hormone , which is secreted by the intestines in response to food

Marquez-Meneses JD, Olaya-Bonilla SA, Barrera-Carreo S, Tibaduiza-Arvalo LC, Forero-Crdenas S, Carrillo-Vaca L, Rojas-Rodrguez LC, Calderon-Ospina CA, Rodrguez-Quintana J

A word of caution: dramatically increasing fiber intake overnight can temporarily worsen gas and bloating

Eli Lilly said the oral GLP-1 pill has been shown to reduce hemoglobin A1C levels -- a blood test that shows average blood sugar levels over two to three months -- by an average of 1.3% to 1.8% in people with diabetes

Knerr PJ, Mowery SA, Douros JD, et al

Endpoints The principal endpoint was the incidence of any malignant neoplasia during the study, reported as a serious adverse event, and the incidence of each of the tumours known as associated with obesity ( Uterine cancer, Oesophageal cancer, Thyroid cancer, Gastric cancer, Colorectal cancer, Liver cancer, Gallbladder cancer and Cholangiocarcinoma, Pancreatic cancer, Breast cancer, Ovary cancer, Kidney cancer, Meningioma, Multiple myeloma ) 6